[How to manage type 2 diabetes in the elderly].

Practitioners are increasing confronted to the management of type 2 diabetes (T2DM) among older patients. Specificities of the elderly should be considered, especially fragility and geriatric syndromes, and glycaemic objectives should be adapted according to the patient's individual profile, «vigorous», «fragile» or «ill», being stricter in individuals with the longer life expectancy. The basics of the therapy of T2DM are similar in older patients as in younger patients with, however, some specificities. A key objective is to avoid hypoglycaemic episodes that are particularly feared among older patients. The therapeutic approach should be personalized. It should take into account both patient's quality of life and environment as well as the presence of comorbidities that could influence the drug choice, for instance atheromatous cardiovascular disease, heart failure and chronic kidney disease.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-02-01
Primary Topic
Diabetes Management and Education
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[How to manage type 2 diabetes in the elderly].

A J Scheen, Emmanuel Beck
PubMed
Diabetes Management and Education
article

[How to manage type 2 diabetes in the elderly].

A J Scheen, Emmanuel Beck
article en

Abstract

Practitioners are increasing confronted to the management of type 2 diabetes (T2DM) among older patients. Specificities of the elderly should be considered, especially fragility and geriatric syndromes, and glycaemic objectives should be adapted according to the patient's individual profile, «vigorous», «fragile» or «ill», being stricter in individuals with the longer life expectancy. The basics of the therapy of T2DM are similar in older patients as in younger patients with, however, some specificities. A key objective is to avoid hypoglycaemic episodes that are particularly feared among older patients. The therapeutic approach should be personalized. It should take into account both patient's quality of life and environment as well as the presence of comorbidities that could influence the drug choice, for instance atheromatous cardiovascular disease, heart failure and chronic kidney disease.

PubMedVol. 80(2)
Centre Hospitalier Chrétien (BE), Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR)
Diabetes Management and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.